Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034305 · ClinicalTrials.gov registry record
Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 7
- Enrollment target
NCT02034305: Completed study, sponsored by University of Pittsburgh.
NCT02034305 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02034305 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine whether airway clearance is augmented by high frequency chest wall oscillation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-01 |
| Est. Completion | 2021-01-01 |
What the finished NCT02034305 record still lists
NCT02034305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02034305 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02034305 about?
NCT02034305 is a clinical study titled "Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy". This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine...
What is the current status of trial NCT02034305?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2014-01. Estimated completion is 2021-01-01.
Who is sponsoring clinical trial NCT02034305?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia